Src tyrosine kinase mediates endothelin-1-induced early growth response protein-1 expression via MAP kinase-dependent

Estelle R Simo-Cheyou1, George Vardatsikos1, Ashok K Srivastava1

  • 1Laboratory of Cellular Signaling, Montreal Diabetes Research Center, Research Center - University of Montreal Hospital Center, Montreal, QC H2X 0A9, Canada.

Insights

The non-receptor protein tyrosine kinase c-Src regulates endothelin-1 induced signaling. This study shows c-Src is critical for ET-1 induced MAPK phosphorylation and Egr-1 expression in vascular smooth muscle cells.

Area of Science:

  • Vascular Biology
  • Cell Signaling
  • Molecular Medicine

Background:

  • The non-receptor protein tyrosine kinase c-Src regulates vascular smooth muscle cell (VSMC) signaling.
  • Endothelin-1 (ET-1) induces early growth response protein-1 (Egr-1) expression, a factor implicated in vascular diseases.
  • The role of c-Src in ET-1-induced mitogen-activated protein kinase (MAPK) signaling and Egr-1 expression is unclear.

Purpose of the Study:

  • To investigate the role of c-Src in ET-1-induced MAPK phosphorylation (ERK1/2, JNK, p38) and Egr-1 expression in rat aortic A10 VSMCs.

Main Methods:

  • Utilized PP2, a specific c-Src inhibitor, to assess its impact on ET-1-induced signaling.
  • Examined ET-1-induced MAPK phosphorylation and Egr-1 expression in c-Src deficient mouse embryonic fibroblasts (SYF).

Main Results:

  • ET-1 rapidly induced MAPK phosphorylation and Egr-1 expression in VSMCs.
  • PP2 treatment dose-dependently inhibited ET-1-induced MAPK phosphorylation and Egr-1 expression.
  • ET-1-induced Egr-1 expression and MAPK phosphorylation were significantly suppressed in c-Src deficient MEFs.

Conclusions:

  • c-Src plays a critical role in mediating ET-1-induced MAPK phosphorylation in VSMCs.
  • c-Src is essential for the regulation of ET-1-induced Egr-1 expression in VSMCs.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
20.3K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.6K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.7K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K